Mandiri Herindo Adiperkasa Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Mandiri Herindo Adiperkasa Tbk. trades at Rp145 (market cap 2.42T, 1.86M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 164.65B, 43.9K 24h volume). The key difference: Mandiri Herindo Adiperkasa Tbk. is far larger — about 14.7× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Mandiri Herindo Adiperkasa Tbk. is more actively traded (1.86M versus 43.9K). Which is the better fit depends on your goals.
| MAHA | OBAT | |
|---|---|---|
Market Cap | 2.42T | 164.65B |
Volume | 1.86M | 43.9K |
Lot | 18.57K | 439 |
Turnover | 267.22M | 10.6M |
Average Price | 143.92 | 241.43 |
Value | 267.22M | 10.6M |
Indicative Equilibrium Price | 145 | 238 |
Indicative Equilibrium Volume | 1.1K | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Mandiri Herindo Adiperkasa Tbk. (the Company) is a limited liability company established in the Republic of Indonesia based on Notarial Deed of Julia Rochana Murat, S.H., No. 18 dated January 25, 1994. The Company started commercial activities in 1994.
Read more on MAHA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →